Explore future economic trends in the generic drug market, including projections to 2030, the rise of biosimilars, and regional growth drivers like Asia's manufacturing boom.
Biosimilars are highly similar versions of complex biologic drugs that work just like the original - but often at a lower cost. They’re not generics. They’re safe, approved, and used daily for conditions like arthritis, cancer, and diabetes.